Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2018 | 75 | 1.37 | Why? |
| Needles | 1 | 2018 | 87 | 0.70 | Why? |
| Neoplasm Grading | 1 | 2017 | 400 | 0.61 | Why? |
| Neuroendocrine Tumors | 1 | 2017 | 241 | 0.52 | Why? |
| Bronchiolitis Obliterans | 3 | 2019 | 86 | 0.41 | Why? |
| Pancreatic Neoplasms | 1 | 2017 | 609 | 0.40 | Why? |
| Lung Neoplasms | 4 | 2019 | 3228 | 0.38 | Why? |
| Ki-67 Antigen | 2 | 2018 | 139 | 0.34 | Why? |
| Lung Transplantation | 4 | 2019 | 1554 | 0.32 | Why? |
| DNA Mutational Analysis | 2 | 2019 | 581 | 0.30 | Why? |
| Granuloma, Pyogenic | 1 | 2001 | 11 | 0.23 | Why? |
| Biomarkers, Tumor | 3 | 2019 | 1314 | 0.21 | Why? |
| Pulmonary Blastoma | 1 | 2019 | 1 | 0.21 | Why? |
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2019 | 4 | 0.21 | Why? |
| Hydroxylamines | 1 | 2021 | 182 | 0.20 | Why? |
| STAT2 Transcription Factor | 1 | 2020 | 141 | 0.20 | Why? |
| Host-Parasite Interactions | 1 | 2020 | 112 | 0.20 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2019 | 27 | 0.20 | Why? |
| Itraconazole | 1 | 2021 | 135 | 0.20 | Why? |
| Cytidine | 1 | 2021 | 219 | 0.20 | Why? |
| Delayed Graft Function | 1 | 2019 | 52 | 0.19 | Why? |
| Nose Diseases | 1 | 2001 | 139 | 0.19 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 45 | 0.19 | Why? |
| Yellow Fever Vaccine | 1 | 2020 | 198 | 0.19 | Why? |
| Cytodiagnosis | 1 | 2019 | 104 | 0.18 | Why? |
| Neutrophil Activation | 1 | 2021 | 510 | 0.18 | Why? |
| Mesothelioma | 1 | 2018 | 76 | 0.17 | Why? |
| Pleura | 1 | 2019 | 178 | 0.17 | Why? |
| Radiotherapy, Image-Guided | 1 | 2017 | 77 | 0.17 | Why? |
| Transforming Growth Factor beta1 | 1 | 2019 | 204 | 0.17 | Why? |
| Cervical Intraepithelial Neoplasia | 1 | 2018 | 114 | 0.17 | Why? |
| Epithelium | 1 | 2019 | 330 | 0.16 | Why? |
| Tumor Microenvironment | 1 | 2018 | 264 | 0.16 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 3633 | 0.15 | Why? |
| Laboratories, Hospital | 1 | 2020 | 489 | 0.15 | Why? |
| Pathology, Clinical | 1 | 2020 | 407 | 0.15 | Why? |
| Radiation Injuries | 1 | 2017 | 140 | 0.15 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.15 | Why? |
| Disease Models, Animal | 7 | 2021 | 10998 | 0.15 | Why? |
| Brain Death | 1 | 2017 | 146 | 0.15 | Why? |
| Vaccines, Attenuated | 1 | 2020 | 952 | 0.14 | Why? |
| Nasal Cavity | 1 | 2001 | 909 | 0.14 | Why? |
| Radiopharmaceuticals | 1 | 2019 | 763 | 0.13 | Why? |
| Genetic Vectors | 1 | 2020 | 1600 | 0.13 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.12 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.12 | Why? |
| Respiratory Mechanics | 1 | 2017 | 585 | 0.12 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2019 | 1153 | 0.11 | Why? |
| Mesocricetus | 3 | 2021 | 1847 | 0.11 | Why? |
| X-Ray Microtomography | 2 | 2021 | 115 | 0.10 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.10 | Why? |
| Workload | 1 | 2020 | 1887 | 0.10 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2019 | 2309 | 0.10 | Why? |
| Uterine Cervical Neoplasms | 1 | 2018 | 842 | 0.10 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.10 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2011 | 310 | 0.10 | Why? |
| Amides | 1 | 2020 | 1864 | 0.09 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 1458 | 0.09 | Why? |
| Indoles | 1 | 2017 | 1243 | 0.09 | Why? |
| Acute Lung Injury | 1 | 2017 | 904 | 0.09 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 100 | 0.09 | Why? |
| Pulmonary Fibrosis | 1 | 2017 | 1068 | 0.08 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.08 | Why? |
| Graft Rejection | 1 | 2018 | 1766 | 0.08 | Why? |
| Proto-Oncogene Proteins B-raf | 2 | 2019 | 179 | 0.08 | Why? |
| ErbB Receptors | 2 | 2019 | 320 | 0.08 | Why? |
| Biopsy | 3 | 2019 | 2811 | 0.08 | Why? |
| Resource Allocation | 1 | 2017 | 1771 | 0.07 | Why? |
| Allografts | 2 | 2019 | 761 | 0.07 | Why? |
| Immunohistochemistry | 3 | 2019 | 2275 | 0.07 | Why? |
| Neoplasm Recurrence, Local | 1 | 2011 | 1063 | 0.07 | Why? |
| Tomography, X-Ray Computed | 4 | 2019 | 25144 | 0.07 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.07 | Why? |
| Virus Replication | 2 | 2021 | 14331 | 0.06 | Why? |
| Carcinoma, Squamous Cell | 1 | 2011 | 902 | 0.06 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.06 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.06 | Why? |
| Lung | 7 | 2020 | 31049 | 0.06 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.06 | Why? |
| Female | 17 | 2021 | 380317 | 0.06 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.06 | Why? |
| Antigen-Presenting Cells | 1 | 2021 | 206 | 0.05 | Why? |
| Animals | 8 | 2021 | 78931 | 0.05 | Why? |
| Epistaxis | 1 | 2001 | 96 | 0.05 | Why? |
| Biopsy, Fine-Needle | 1 | 2020 | 274 | 0.05 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.05 | Why? |
| Head and Neck Neoplasms | 1 | 2011 | 1568 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Drug Evaluation, Preclinical | 2 | 2021 | 3347 | 0.05 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Electrosurgery | 1 | 2018 | 35 | 0.05 | Why? |
| Proof of Concept Study | 1 | 2021 | 696 | 0.05 | Why? |
| Pleural Diseases | 1 | 1999 | 68 | 0.05 | Why? |
| Histocompatibility Antigens Class II | 1 | 2021 | 383 | 0.05 | Why? |
| Survival Analysis | 3 | 2018 | 7592 | 0.05 | Why? |
| Stromal Cells | 1 | 2018 | 105 | 0.04 | Why? |
| Colposcopy | 1 | 2018 | 89 | 0.04 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 43 | 0.04 | Why? |
| Fibrosis | 2 | 2018 | 800 | 0.04 | Why? |
| Staining and Labeling | 1 | 2018 | 169 | 0.04 | Why? |
| GTP Phosphohydrolases | 1 | 2017 | 89 | 0.04 | Why? |
| Reproducibility of Results | 3 | 2019 | 11304 | 0.04 | Why? |
| Partial Pressure | 1 | 2017 | 279 | 0.04 | Why? |
| Humans | 20 | 2021 | 930598 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Pulmonary Emphysema | 1 | 2018 | 122 | 0.04 | Why? |
| Gene Expression Regulation | 2 | 2021 | 4020 | 0.04 | Why? |
| Blotting, Western | 1 | 2019 | 863 | 0.04 | Why? |
| Peroxidase | 1 | 2017 | 207 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Calcinosis | 1 | 1999 | 240 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| Glycosylation | 1 | 2020 | 1255 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2019 | 757 | 0.04 | Why? |
| Macaca fascicularis | 1 | 2020 | 1009 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2019 | 632 | 0.04 | Why? |
| Graft Survival | 1 | 2019 | 587 | 0.04 | Why? |
| Mice | 3 | 2020 | 21357 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 347 | 0.04 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.03 | Why? |
| Bronchoalveolar Lavage | 1 | 2018 | 603 | 0.03 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.03 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.03 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.03 | Why? |
| Neoplasms | 2 | 2019 | 17251 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Myeloid Cells | 1 | 2018 | 808 | 0.03 | Why? |
| Safety | 1 | 2020 | 1583 | 0.03 | Why? |
| Extracellular Traps | 1 | 2021 | 1036 | 0.03 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Interleukins | 1 | 2017 | 762 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Transcriptional Activation | 1 | 2011 | 196 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Saccharomyces cerevisiae | 1 | 2011 | 339 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Mucous Membrane | 1 | 2011 | 305 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2018 | 2290 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Single-Cell Analysis | 1 | 2018 | 2450 | 0.02 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Lung Diseases, Interstitial | 1 | 2018 | 1476 | 0.02 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| Adult | 7 | 2019 | 244371 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Tissue and Organ Procurement | 1 | 2017 | 1277 | 0.02 | Why? |
| Alleles | 1 | 2011 | 1557 | 0.02 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1014 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2021 | 243684 | 0.02 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2018 | 4418 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 7868 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| T-Lymphocytes | 1 | 2018 | 6670 | 0.01 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.01 | Why? |
| Granuloma, Plasma Cell | 1 | 1999 | 7 | 0.01 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Pleural Neoplasms | 1 | 1999 | 71 | 0.01 | Why? |
| Pregnancy | 1 | 2001 | 23879 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Collagen | 1 | 1999 | 222 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Plasma Cells | 1 | 1999 | 464 | 0.01 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 13720 | 0.01 | Why? |
| Child | 1 | 2001 | 70012 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Lymphocytes | 1 | 1999 | 3056 | 0.00 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
| Diagnosis, Differential | 1 | 1999 | 7220 | 0.00 | Why? |
Weynand's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(202)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(254)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_